ArticleScientific reports2025

The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.

Siyang Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.